CCNG2 and neoplasm: In the TCGA pan cancer dataset, including 33 tumor entities, CCNG2 expression is decreased in metastasis compared to primary tumors (Fig. 6F) and low expression of CCNG2 is also associated with worse patient overall survival (Fig. 6G) and decreased progression free survival (Figure S4).